NCT07519707 Video Intervention to Improve Understanding of Diabetic Retinopathy at Zuckerberg San Francisco General Hospital and Trauma Center
| NCT ID | NCT07519707 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Diabetic Retinopathy (DR) |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2026-05 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2026-05 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study will evaluate whether videos can improve understanding of diabetic eye disease, and follow-up rates in the eye clinic.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of diabetes mellitus with or without diabetic retinopathy * Scheduled visit to ZSFG clinic is specifically for diabetes mellitus or diabetic retinopathy care * Able to speak and understand English or Spanish Exclusion Criteria: * Unable to view or understand the videos due to significant vision obstruction or impairment
Contact & Investigator
Sriranjani Padmanabhan, MD
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT07519707 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Diabetic Retinopathy (DR). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07519707 currently recruiting?
Yes, NCT07519707 is actively recruiting participants. Contact the research team at eyestudy@ucsf.edu for enrollment information.
Where is the NCT07519707 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT07519707 clinical trial?
NCT07519707 is sponsored by University of California, San Francisco. The principal investigator is Sriranjani Padmanabhan, MD at University of California, San Francisco. The trial plans to enroll 150 participants.